Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT05414916 Recruiting - Pain Clinical Trials

Pain Relief Strategies for Dressing Change in Chronic Wounds

Start date: April 5, 2022
Phase:
Study type: Observational

A small-scale study using interviews to explore patients', carers' and health care professionals' experience of pain relief strategies currently used in UK practice for dressing change in chronic wounds.

NCT ID: NCT05414370 Recruiting - Acute Lung Injury Clinical Trials

Hyperoxia Induced Pulmonary Inflammation and Organ Injury: a Human in Vivo Model

Start date: December 2, 2022
Phase: N/A
Study type: Interventional

Oxygen is the most commonly administered therapy in critical illness. Accumulating evidence suggests that patients often achieve supra-physiological levels of oxygenation in the critical care environment. Furthermore, hyperoxia related complications following cardiac arrest, myocardial infarction and stroke have also been reported. The underlying mechanisms of hyperoxia mediated injury remain poorly understood and there are currently no human in vivo studies exploring the relationship between hyperoxia and direct pulmonary injury and inflammation as well as distant organ injury. The current trial is a mechanistic study designed to evaluate the effects of prolonged administration of high-flow oxygen (hyperoxia) on pulmonary and systemic inflammation. The study is a randomised, double-blind, placebo-controlled trial of high-flow nasal oxygen therapy versus matching placebo (synthetic medical air). We will also incorporate a model of acute lung injury induced by inhaled endotoxin (LPS) in healthy human volunteers. Healthy volunteers will undergo bronchoalveolar lavage (BAL) at 6 hours post-intervention to enable measurement of pulmonary and systemic markers of inflammation, oxidative stress and cellular injury.

NCT ID: NCT05414253 Recruiting - Wound Heal Clinical Trials

Evaluation of Chlorhexidine Plus Hyaluronic Acid Mouthwash in Surgical Wound Healing Following Third Molar Surgery (CLOR_4)

CLOR_4
Start date: June 1, 2022
Phase: N/A
Study type: Interventional

Evaluation of the response of gingival tissues to the use of mouthwash with chlorhexidine and chlorhexidine + hyaluronic acid in terms of healing of the surgical wound following third molar surgery.

NCT ID: NCT05413499 Recruiting - Clinical trials for Traumatic Brain Injury

Blood Biomarkers to Improve Management of Children With Traumatic Brain Injury

BRAINI2
Start date: August 2, 2022
Phase: N/A
Study type: Interventional

Mild traumatic brain injury (TBI), defined by a Glasgow Coma Scale (GCS) score of 13 to 15, is the cause of many consultations in paediatric emergency departments (1), even though it is a rare cause of acute complication: approximately 10% of children present with intracranial lesions (ICL) on the CT scan and less than 1% require neurosurgical intervention (2). Although ICLs remain a serious complication requiring rapid diagnosis, brain CT scans, the gold standard diagnostic test, cannot be performed routinely because many children would be unnecessarily exposed to ionising radiation associated with an increased risk of cancer (3). In recent years, several clinical decision rules for the management of mTBI have therefore been developed with the aim of identifying children at high or very low risk of ICL in order to better target CT scan indications. Despite this, the rate of CT scans performed has remained high, up to 35%, and has not decreased with the application of these clinical decision rules (4). Furthermore, even though the majority of children and adolescents recover quickly after mTBI, nearly 30% will present symptoms such as headaches, dizziness, asthenia, memory, concentration or sleep disorders persisting beyond one month with a possible impact on their quality of life (5). Thus, there is a need to develop new strategies to (i) limit the use of CT scans while minimising the risk of late diagnosis of ICL, (ii) identify children with a higher risk of adverse outcome and/or post-concussive symptoms. One of the most promising strategies is the use of brain-based blood biomarkers. This study therefore aims to provide new knowledge on two of them, GFAP and UCH-L1 (6,7), in particular by using an automated test combining them (the VIDAS® TBI test developed by bioMérieux) in order to improve the management of CT in the paediatric population at the diagnostic and prognostic levels.

NCT ID: NCT05411731 Completed - Obstetric; Injury Clinical Trials

Modified Constraint Induced Movement Therapy in Children With Obstetric Brachial Plexus Injury

Start date: April 30, 2022
Phase: N/A
Study type: Interventional

The aim of this study was to increase and improve the use of affected extremity in obstetric brachial plexus palsy children while restricting the use of less affected arm and the purpose was to improve the function, Range of motion and disability in affected arm of children with brachial plexus injury.

NCT ID: NCT05411692 Completed - Spinal Cord Injury Clinical Trials

Functional Electrical Stimulations With and Without Motor Priming Exercises in Spinal Cord Injury

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

As functional electrical stimulations has evident role in improving motor control in tenodesis function (power and precision grip) but its results are considered to be short term so addition of task oriented approach i.e. motor priming exercises could enhance the treatment effects . Priming is a mechanism that could easily be a part of a restorative occupational therapy approach, is a therapeutic method with the intent to improve function by targeting underlying neural mechanisms (neuroplasticity and motor control). This will yield the long term effects of priming augmented functional electrical stimulations to enhance the tenodesis function of patients with spinal cord injury. Their combination may produce improvement in hand functions dexterity in spinal cord injury patients.

NCT ID: NCT05411484 Recruiting - Wounds and Injury Clinical Trials

Investigation of Laser Assisted Drug Delivery of NanoDOX®

Start date: November 29, 2023
Phase: Phase 2
Study type: Interventional

This is a self-controlled single-site study of 10 healthy subjects receiving an ablative fractional CO2 laser procedure followed by topical application of NanoDOX® Hydrogel (1% doxycycline). The study includes skin biopsies to evaluate the effects of NanoDOX® Doxycycline Monohydrate Gel on wound healing after the ablative laser procedure. Study subjects will be asked to do two visits of approximately 4 hours over two weeks.

NCT ID: NCT05410158 Not yet recruiting - Clinical trials for Ketamine, Pecs Block, Topical Wound Instillation , Modefied Radical Mastectomy

Comparative Study of Ketamine Added to Bupivacaine in PECS Block Versus Topical Wound Instillation on Post Operative Analgesia in Modified Radical Mastectomy Surgery

Start date: May 15, 2023
Phase: Early Phase 1
Study type: Interventional

Comparative study of ketamine added to bupivacaine in PECS block versus topical wound instillation on post operative analgesia in modified radical mastectomy surgery

NCT ID: NCT05409690 Recruiting - Acute Kidney Injury Clinical Trials

Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury

Start date: May 10, 2022
Phase:
Study type: Observational

early differential diagnosis of anticipated acute kidney injury via ultrasound renal resistive index calculation

NCT ID: NCT05408988 Recruiting - Clinical trials for Subarachnoid Hemorrhage

Neurogenic Myocardial and Lung Injury in SAH Patients

Start date: January 22, 2022
Phase:
Study type: Observational

Up to this day, little is known whether the extent of brain damage in patients with SAH correlates with the degree neurogenic myocardial injury and neurogenic lung injury. This is a prospective observational study designed to asses relationship between catecholamine surge and development of myocardial and lung injury in subarachnoid haemorrhage patients.